TipRanks
Go Ultimate55% OFF

Ehealth (M5V) Stock Price & Analysis

M5V Stock Chart & Stats

€0.45-€0.05(-10.67%)
At close: 5:30 PM GMT+1
EUR 0.5EUR 0.75EUR 16 Aug2 Sep28 Oct
Day’s Range
EUR 0.45 - EUR 0.45
52-Week Range
EUR 0.45 - EUR 4.43
Previous Close
EUR 0.51
Volume
0
Average Volume (3M)
210
Market Cap
EUR 14.07M
Enterprise Value
EUR 484.76M
Total Cash (Recent Filing)
EUR 101.05M
Total Debt (Recent Filing)
EUR 132.17M
Price to Earnings (P/E)
―
Beta
0.51
Next Earnings
Nov 04, 2026 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Manageable Leverage

Manageable leverage provides eHealth with balance-sheet flexibility while it executes its turnaround. A sizable equity base and stable debt can help absorb operating volatility, preserve funding options, and support investment in technology and distribution capabilities over the next several quarters.

Structural Cost Savings And AI Efficiency

The planned cost reductions are substantial relative to the company’s recent expense base, while AI is being applied to screening, customer interactions, and carrier-content workflows. If sustained, these initiatives can lower service costs and improve operating leverage as enrollment recovers.

Lifetime Advisory Model Expansion

The lifetime advisory model could deepen customer relationships beyond the initial enrollment and broaden revenue opportunities through ancillary products. Early cross-sell improvement, combined with management’s retention and lifetime-value objectives, supports a potentially more durable distribution advantage.

Bears Say

Persistent Negative Cash Generation

Persistent negative operating and free cash flow weakens earnings quality because reported profitability has not translated into internally generated cash. Continued cash consumption could reduce flexibility to fund marketing, technology, and customer support while increasing reliance on existing liquidity.

Sharp Revenue And Enrollment Contraction

The simultaneous decline in revenue and Medicare submissions indicates a material contraction in the company’s core enrollment engine, not merely margin pressure. Lower volume can reduce commission income, weaken carrier economics, and make fixed platform and service costs harder to absorb.

Medicare Gross-profit Compression

A roughly 69% decline in Medicare gross profit materially reduces the economic value of eHealth’s main business segment. If lower enrollment and reduced tail revenue persist, the company may have less capacity to reinvest in acquisition, service quality, and platform improvements.

Ehealth News

M5V FAQ

What was Ehealth’s price range in the past 12 months?
Ehealth lowest stock price was €0.45 and its highest was €4.43 in the past 12 months.
What is Ehealth’s market cap?
Ehealth’s market cap is €14.07M.
When is Ehealth’s upcoming earnings report date?
Ehealth’s next earnings report is estimated for Nov 04, 2026 (not yet confirmed), which is in 2 days.
How were Ehealth’s earnings last quarter?
Ehealth released its earnings results on Aug 04, 2026. The company reported -€0.989 earnings per share for the quarter, missing the consensus estimate of -€0.751 by -€0.238.
Is Ehealth overvalued?
According to Wall Street analysts Ehealth’s price is currently Undervalued.
Does Ehealth pay dividends?
Ehealth does not currently pay dividends.
What is Ehealth’s EPS estimate?
Ehealth’s EPS estimate is -0.98.
How many shares outstanding does Ehealth have?
Ehealth has 32,032,654 shares outstanding.
What happened to Ehealth’s price movement after its last earnings report?
Ehealth reported an EPS of -€0.989 in its last earnings report, missing expectations of -€0.751. Following the earnings report the stock price went up 0.847%.
Which hedge fund is a major shareholder of Ehealth?
Hedge funds hold Ehealth shares: the largest hedge-fund position in Ehealth is 206,185,740 shares, and hedge funds decreased their holdings by 19.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology